Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy

Helsinki University Central Hospital300 enrolled

Overview

This is an observational study where prostate cancer related PROMs (EPIC-26) is collected using two different methods (by paper questionnaires and electronically) and patient experience and preference is asked.

Prostate cancer patients that are treated with radiation therapy for local prostate cancer receive EPIC-26 before treatment and during follow-up. EPIC-26 is collected both traditionally using paper questionnaires and electronically. Patients experience and preference for these are asked.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Prostate Cancer

Interventions

electronic PROMs questionnaireOTHER

Patients are asked to complete EPIC-26 questionnaire in paper and electronically

Eligibility

Sex: MALEMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * cT1-4N0M0, gleason 6-10, PSA \< 100, WHO ≤ 2 prostate cancer eligible for radiation therapy * willing to complete EPIC-26 questionnaires both in paper and electronically * willing to consent for the study Exclusion Criteria: * not able to complete EPIC-26 both in paper and electronically

Locations (1)

Helsinki University Hospital

Helsinki, Uusimaa, Finland

Outcomes

Primary Outcomes

preference

patient preference for type of questionnaire (paper versus electronic)

Time frame: through study completion, an average of 1 year

Secondary Outcomes

QoL as measured using the validated EPIC-26 questionnaire

Patient QoL after RT (EPIC-26, scale 0-100)

Time frame: through study completion, an average of 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.